ICD-10 Coding for Lymphoma(C83.3, C83.3A, C83.3D)
Explore detailed ICD-10 coding for lymphoma, including remission codes, documentation requirements, and coding pitfalls.
Complete code families applicable to Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.3 | Diffuse large B-cell lymphoma | Use when DLBCL is confirmed by pathology and is active. |
|
| C83.3A | Diffuse large B-cell lymphoma, in remission | Use when DLBCL is in remission as confirmed by imaging. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutLymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Lymphoma.
Omitting subtype in documentation
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Ensure pathology reports are complete, Include subtype in all documentation
Using unspecified codes when specific ones are available
Impact
Reimbursement: May lead to reduced reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation
Ensure documentation specifies subtype and remission status.
Remission documentation
Impact
Lack of documentation for remission status.
Mitigation
Ensure imaging results are included in patient records.